206 related articles for article (PubMed ID: 29851855)
21. Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric technique.
Kim SI; Yoon S; Kim TM; Cho JY; Chung HH; Song YS
Gynecol Oncol; 2021 Jul; 162(1):72-79. PubMed ID: 33994146
[TBL] [Abstract][Full Text] [Related]
22. Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients.
Wochner R; Clauss D; Nattenmüller J; Tjaden C; Bruckner T; Kauczor HU; Hackert T; Wiskemann J; Steindorf K
PLoS One; 2020; 15(11):e0242785. PubMed ID: 33253318
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer.
Salinas-Miranda E; Deniffel D; Dong X; Healy GM; Khalvati F; O'Kane GM; Knox J; Bathe OF; Baracos VE; Gallinger S; Haider MA
Eur Radiol; 2021 Nov; 31(11):8662-8670. PubMed ID: 33934171
[TBL] [Abstract][Full Text] [Related]
24. Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: A comprehensive analysis from a large-scale prospective study.
Dong QT; Cai HY; Zhang Z; Zou HB; Dong WX; Wang WB; Song HN; Luo X; Chen XL; Huang DD
Clin Nutr; 2021 May; 40(5):3360-3369. PubMed ID: 33223117
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
26. Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis.
Katsui K; Ogata T; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
Sci Rep; 2021 Jun; 11(1):11882. PubMed ID: 34088965
[TBL] [Abstract][Full Text] [Related]
27. Associations of Abdominal Skeletal Muscle Mass, Fat Mass, and Mortality among Men and Women with Stage I-III Colorectal Cancer.
van Baar H; Winkels RM; Brouwer JGM; Posthuma L; Bours MJL; Weijenberg MP; Boshuizen HC; van Zutphen M; van Duijnhoven FJB; Kok DE; Wesselink E; Slooter GD; Spillenaar Bilgen EJ; Hansson BME; de Wilt JHW; Kampman E; Beijer S
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):956-965. PubMed ID: 32132148
[TBL] [Abstract][Full Text] [Related]
28. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer.
van Dijk DP; Bakens MJ; Coolsen MM; Rensen SS; van Dam RM; Bours MJ; Weijenberg MP; Dejong CH; Olde Damink SW
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):317-326. PubMed ID: 27897432
[TBL] [Abstract][Full Text] [Related]
29. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.
Maurits JSF; Sedelaar JPM; Mulders PFA; Aben KKH; Kiemeney LALM; Vrieling A
Clin Nutr; 2022 Jan; 41(1):131-143. PubMed ID: 34872047
[TBL] [Abstract][Full Text] [Related]
31. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer.
Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Masui T; Mizumoto M; Hammad A; Mori A; Takaori K; Uemoto S
Surgery; 2015 Jun; 157(6):1088-98. PubMed ID: 25799468
[TBL] [Abstract][Full Text] [Related]
32. Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international study.
Lin JX; Tang YH; Zhou WX; Desiderio J; Parisi A; Xie JW; Wang JB; Cianchi F; Antonuzzo L; Borghi F; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Staderini F; Marano A; Peluso C; Li P; Zheng CH; Ma YB; Huang CM
Clin Nutr; 2021 Aug; 40(8):4980-4987. PubMed ID: 34364237
[TBL] [Abstract][Full Text] [Related]
33. Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients.
Kwon MR; Ko ES; Park MS; Jeong WK; Hwang NY; Kim JH; Lee JE; Kim SW; Yu JH; Han BK; Ko EY; Choi JS; Park KW
Korean J Radiol; 2022 Feb; 23(2):159-171. PubMed ID: 35029082
[TBL] [Abstract][Full Text] [Related]
34. Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.
Babic A; Rosenthal MH; Bamlet WR; Takahashi N; Sugimoto M; Danai LV; Morales-Oyarvide V; Khalaf N; Dunne RF; Brais LK; Welch MW; Zellers CL; Dennis C; Rifai N; Prado CM; Caan B; Sundaresan TK; Meyerhardt JA; Kulke MH; Clish CB; Ng K; Vander Heiden MG; Petersen GM; Wolpin BM
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2062-2069. PubMed ID: 31533940
[TBL] [Abstract][Full Text] [Related]
35. Impact of preoperative body compositions on survival following resection of biliary tract cancer.
Yoon SB; Choi MH; Song M; Lee JH; Lee IS; Lee MA; Hong TH; Jung ES; Choi MG
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):794-802. PubMed ID: 31037838
[TBL] [Abstract][Full Text] [Related]
36. The relationship between the mode of presentation, CT-derived body composition, systemic inflammatory grade and survival in colon cancer.
Golder AM; Sin LKE; Alani F; Alasadi A; Dolan R; Mansouri D; Horgan PG; McMillan DC; Roxburgh CS
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2863-2874. PubMed ID: 36218135
[TBL] [Abstract][Full Text] [Related]
37. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
Zouhry Y; Taibi A; Durand-Fontanier S; Darbas T; Forestier G; Monteil J; Lebrun-Ly V; Fayemendy P; Leobon S; Jesus P; Deluche E
BMC Cancer; 2021 Dec; 21(1):1313. PubMed ID: 34876055
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer.
Song EJ; Lee CW; Jung SY; Kim BN; Lee KS; Lee S; Kang HS; Park IH; Lee MH; Kim YJ; Ko K; Kim S; Nam BH; Lee ES
Breast Cancer Res Treat; 2018 Nov; 172(2):425-436. PubMed ID: 30132218
[TBL] [Abstract][Full Text] [Related]
39. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
[TBL] [Abstract][Full Text] [Related]
40. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]